Abstract
The aim of the study was to determine the developmental toxicity of the traditional Chinese medicine Xiaoaiping (XAP) and to investigate its underlying mechanism of action. Zebrafish embryos were incubated with 0.4, 0.8, 1.2, and 1.6 mg/mL XAP. Endpoints such as mortality, hatching rate, malformation, body length, morphology score, swimming behavior, histological changes, reactive oxygen species (ROS) production, total superoxide dismutase (T-SOD) activity, and the mRNA expression of genes related to oxidative stress, endoplasmic reticulum (ER) stress, apoptosis, and the Wnt pathway were evaluated. Our results demonstrated that XAP exposure increased mortality and malformation and reduced the hatching rate. XAP resulted in severe malformation, including swim bladder deficiency, yolk retention, pericardial edema, and tail curvature. Histopathological analysis showed that XAP induced liver, heart and muscle injury. High doses (≥1.2 mg/mL) of XAP notably decreased the locomotor capacity of zebrafish. ROS generation was remarkably increased and T-SOD activity was decreased, confirming that oxidative stress was induced by XAP. The mRNA expression levels of ER stress-related genes (chop, hspa5, hsp90b1, and perk), apoptosis-related genes (caspase-3, bax, and p53) and wnt11 were significantly upregulated by XAP exposure. The expression levels of the oxidative stress-related genes (cat, sod1, and gstp2), Wnt pathway-related genes (β-catenin, wnt3a, and wnt8a) and bcl-2 initially increased and then decreased as the XAP exposure dose increased. In conclusion, we provide evidence for the first time that XAP can induce dose-related developmental toxicity, and ER stress, apoptosis and the Wnt pathway participate in the toxicity regulation.
Highlights
XAP, which is an extract derived from Marsdenia tenacissima, has been widely used for the treatment of cancer in China
We revealed that XAP resulted in developmental toxicity in wild-type AB-strain zebrafish embryos, morphological abnormalities, and delayed hatching
The 0.4, 0.8, 1.2, 1.6, and 2.4 mg/mL doses chosen for the toxicity studies in zebrafish model ranged from no effect on the development to clear the toxic effect on development
Summary
XAP, which is an extract derived from Marsdenia tenacissima, has been widely used for the treatment of cancer in China. XAP, as an extract of M. tenacissima, has a wide pharmacological action, in gastric cancer, oesophageal cancer, lung cancer, and liver cancer (Han et al, 2012; Huang et al, 2013b; Pang et al, 2016). It has been applied alone or combined with chemotherapy or radiotherapy to treat cancers in China Our study aims to investigate the developmental toxicity induced by XAP
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.